Sarah Romano Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sarah Romano.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sarah Romano. Sarah Romano is Chief Financial Officer in EYEGATE PHARMACEUTICALS INC ($EYEG) and Interim CFO in EYEGATE PHARMACEUTICALS INC ($EYEG).
Latest Insider Trading Transactions of Sarah Romano
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2021 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 4.13 | 177 | 731 | 23,756 | 23.9 K to 23.8 K (-0.74 %) |
| Apr 09 2021 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 4.94 | 180 | 889 | 23,933 | 24.1 K to 23.9 K (-0.75 %) |
| Mar 05 2021 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 5.46 | 218 | 1,190 | 24,113 | 24.3 K to 24.1 K (-0.90 %) |
| Feb 03 2021 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Option Exercise | A | 6.46 | 30,000 | 193,800 | 30,000 | |
| Feb 03 2021 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 6.34 | 1,282 | 8,128 | 24,331 | 25.6 K to 24.3 K (-5.01 %) |
| Dec 08 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 3.76 | 91 | 342 | 25,728 | 25.8 K to 25.7 K (-0.35 %) |
| Nov 03 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 3.51 | 97 | 340 | 25,819 | 25.9 K to 25.8 K (-0.37 %) |
| Oct 05 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 3.88 | 98 | 380 | 25,916 | 26 K to 25.9 K (-0.38 %) |
| Sep 03 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 3.94 | 97 | 382 | 26,014 | 26.1 K to 26 K (-0.37 %) |
| Aug 05 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 4.11 | 95 | 390 | 26,111 | 26.2 K to 26.1 K (-0.36 %) |
| Jul 06 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 4.82 | 97 | 468 | 26,206 | 26.3 K to 26.2 K (-0.37 %) |
| Jun 04 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 5.11 | 94 | 480 | 26,303 | 26.4 K to 26.3 K (-0.36 %) |
| May 06 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 5.10 | 93 | 474 | 26,397 | 26.5 K to 26.4 K (-0.35 %) |
| Apr 03 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 4.97 | 122 | 606 | 26,490 | 26.6 K to 26.5 K (-0.46 %) |
| Mar 10 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 5.01 | 130 | 651 | 26,612 | 26.7 K to 26.6 K (-0.49 %) |
| Feb 19 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Option Exercise | A | 6.55 | 10,000 | 65,500 | 10,000 | |
| Feb 19 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 26,742 | 16.7 K to 26.7 K (+59.73 %) |
| Feb 05 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 6.00 | 109 | 654 | 16,742 | 16.9 K to 16.7 K (-0.65 %) |
| Jan 06 2020 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 9.52 | 119 | 1,133 | 16,851 | 17 K to 16.9 K (-0.70 %) |
| Dec 20 2019 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 7.46 | 101 | 753 | 16,970 | 17.1 K to 17 K (-0.59 %) |
| Nov 07 2019 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 3.85 | 108 | 416 | 17,071 | 17.2 K to 17.1 K (-0.63 %) |
| Oct 11 2019 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 3.10 | 185 | 574 | 17,179 | 17.4 K to 17.2 K (-1.07 %) |
| Aug 07 2019 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Payment of Exercise | F | 0.21 | 1,649 | 346 | 260,464 | 262.1 K to 260.5 K (-0.63 %) |
| Jul 15 2019 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Sell | S | 0.23 | 6,584 | 1,534 | 262,113 | 268.7 K to 262.1 K (-2.45 %) |
| Jul 15 2019 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Sell | S | 0.24 | 6,583 | 1,551 | 268,697 | 275.3 K to 268.7 K (-2.39 %) |
| Jul 15 2019 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Sell | S | 0.24 | 6,583 | 1,584 | 275,280 | 281.9 K to 275.3 K (-2.34 %) |
| Jul 15 2019 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Sell | S | 0.23 | 6,584 | 1,534 | 262,113 | 268.7 K to 262.1 K (-2.45 %) |
| Jul 15 2019 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Sell | S | 0.24 | 6,583 | 1,551 | 268,697 | 275.3 K to 268.7 K (-2.39 %) |
| Jul 15 2019 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Sell | S | 0.24 | 6,583 | 1,584 | 275,280 | 281.9 K to 275.3 K (-2.34 %) |
| Feb 05 2019 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Option Exercise | A | 0.48 | 50,000 | 24,000 | 50,000 | |
| Jul 12 2018 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Grant | A | 0.00 | 175,000 | 0 | 281,863 | 106.9 K to 281.9 K (+163.76 %) |
| Apr 18 2018 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Option Exercise | P | 0.32 | 62,500 | 20,000 | 62,500 | |
| Apr 18 2018 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Buy | P | 0.00 | 62,500 | 0 | 106,863 | 44.4 K to 106.9 K (+140.88 %) |
| Mar 01 2018 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Option Exercise | A | 0.57 | 25,000 | 14,250 | 25,000 | |
| Jan 03 2018 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Chief Financial Off ... | Buy | J | 1.01 | 11,863 | 11,982 | 44,363 | 32.5 K to 44.4 K (+36.50 %) |
| Aug 17 2017 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Interim CFO | Buy | P | 1.00 | 10,000 | 10,000 | 32,500 | 22.5 K to 32.5 K (+44.44 %) |
| Jun 22 2017 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Interim CFO | Option Exercise | A | 1.35 | 40,000 | 54,000 | 40,000 | |
| Jun 14 2017 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Interim CFO | Option Exercise | P | 1.50 | 20,000 | 30,000 | 20,000 | |
| Jun 14 2017 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Interim CFO | Buy | P | 0.00 | 20,000 | 0 | 22,500 | 2.5 K to 22.5 K (+800.00 %) |
| Feb 08 2017 | EYEG | EYEGATE PHARMACEUT ... | Romano Sarah | Interim CFO | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Page: 1